Inhaled hypertonic saline after pediatric lung transplant-Caution required?

Area of Science:

• Pulmonary Medicine
• Transplant Surgery
• Pediatric Critical Care

Background:

• Management of pulmonary infection post-lung transplant involves respiratory physiotherapy.
• Inhaled hypertonic saline (HTS) is a potential adjunct therapy in pediatric transplant patients.

Purpose of the Study:

• To evaluate the effect of inhaled HTS in the acute post-operative period for pediatric lung transplant patients.
• To investigate the safety and efficacy of HTS as an adjunct to respiratory physiotherapy.

Main Methods:

• Retrospective case-note review at a single UK pediatric transplant center.
• Comparison of an intervention group receiving HTS with a historical control group.
• Frequency matching for age, gender, and diagnosis (14 patients per group).

Main Results:

• The control group had significantly shorter median days of invasive ventilation (1 vs 2 days, P < .05).
• The control group had a significantly shorter median length of stay (23 vs 31 days, P < .05).
• Trends suggested higher non-invasive ventilation and oxygen use in the HTS group, though not statistically significant.

Conclusions:

• This study indicates uncertainty regarding the safety of inhaled HTS in the acute post-operative period after pediatric lung transplant.
• A trend towards poorer acute outcomes was observed in patients receiving HTS.
• Larger sample size studies are required to definitively assess the impact of HTS in this patient population.